Page 483 Cite

Suggested Citation:"Appendix H: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Premium Cigars: Patterns of Use, Marketing, and Health Effects. Washington, DC: The National Academies Press. doi: 10.17226/26421.

×

Appendix H

Public Meeting Agendas

FIRST PUBLIC MEETING

March 9, 2021
Videoconference via Zoom

2:00	Welcome Steve Teutsch, Committee Chair
2:05–3:00	Presentation of the statement of task, background, and discussion Benjamin Apelberg Office of Science, Center for Tobacco Products, Food and Drug Administration On behalf of Matthew Holman Director, Office of Science, Center for Tobacco Products, Food and Drug Administration
3:00	Closing remarks/open session adjourn

Page 484 Cite

Suggested Citation:"Appendix H: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Premium Cigars: Patterns of Use, Marketing, and Health Effects. Washington, DC: The National Academies Press. doi: 10.17226/26421.

×

SECOND PUBLIC MEETING

April 20, 2021
Videoconference via Zoom

1:00–1:10	Welcome Steve Teutsch, Committee Chair
1:10–2:10	Public comment The National Academies of Sciences, Engineering, and Medicine invites the public to provide comments to be considered by the Committee on Health Effects and Patterns of Use of Premium Cigars.
	At this meeting (April 20, 2021), the committee welcomes input on the draft research questions provided to the committee by the report sponsors (the Food and Drug Administration and the National Institutes of Health)—available here. If you would like to provide oral comments at the meeting, please send an email with your name and affiliation to PremiumCigars@nas.edu (each individual will have up to 5 minutes).
	Members of the public may also submit written comments for consideration by the study committee (as individuals or on behalf of an organization) via email to PremiumCigars@nas.edu.
	All materials and comments received will be placed in the committee’s public access file and may be provided to the public upon request. Materials and comments received may also be included in the committee’s report.
2:10–2:15	Closing remarks/open session adjourn

Page 485 Cite

Suggested Citation:"Appendix H: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Premium Cigars: Patterns of Use, Marketing, and Health Effects. Washington, DC: The National Academies Press. doi: 10.17226/26421.

×

April 23, 2021
Videoconference via Zoom

1:00–1:10	Welcome Steve Teutsch, Committee Chair
1:10–2:00	Tobacco Science David L. Ashley Research Professor, Georgia State University School of Public Health K. Michael Cummings Professor, Medical University of South Carolina
2:00–3:15	Perspectives of Premium Cigars from Producers, Retailers, and Consumers Thomas Lindegaard Senior Vice President of Scientific and Regulatory Affairs, Scandinavian Tobacco Group; Coordinator, CORESTA Sub-Group on Cigar Smoking Methods Richard Voith President, Econsult Solutions, Inc. Gerald Long Manager of Scientific Affairs, ITG Brands, LLC Scott Pearce Executive Director, Premium Cigar Association Mike Copperman Legislative Director, Cigar Rights of America Drew Newman (Discussant) Owner and General Counsel, J.C. Newman Cigar Company Barry S. Schaevitz (Discussant) Partner, Fox Rothschild, LLP
3:15–3:30	Break
3:30–4:30	Tobacco Control and Policy Perspectives Ann Boonn Director of Research, Campaign for Tobacco-Free Kids Barbara Schillo Senior Vice President, Truth Initiative Schroeder Institute

Page 486 Cite

Suggested Citation:"Appendix H: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Premium Cigars: Patterns of Use, Marketing, and Health Effects. Washington, DC: The National Academies Press. doi: 10.17226/26421.

×

	Joelle M. Lester Director of Commercial Tobacco Control Programs, Public Health Law Center at Mitchell Hamline School of Law Dennis A. Henigan (Discussant) Vice President for Legal and Regulatory Affairs, Campaign for Tobacco-Free Kids
4:30	Closing remarks/open session adjourn

THIRD PUBLIC MEETING

May 28, 2021
Videoconference via Zoom

2:00–2:10	Welcome Steve Teutsch, Committee Chair
2:10–3:15	Tobacco Product Chemistry and Science Clifford Watson Director of Tobacco Products Laboratory, Centers for Disease Control and Prevention Benjamin Blount Research Chemist, Centers for Disease Control and Prevention Bartosz Koszowski Division Manager of Individual and Population Health, Battelle
3:15–4:05	Health Effects of Premium Cigars Benjamin Chaffee Associate Professor, University of California, San Francisco School of Dentistry Mia Hashibe Professor, Department of Family and Preventive Medicine, University of Utah; Scientific Coordinator, International Head and Neck Cancer Epidemiology (INHANCE) Consortium
4:05–4:20	Break

Page 487 Cite

Suggested Citation:"Appendix H: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Premium Cigars: Patterns of Use, Marketing, and Health Effects. Washington, DC: The National Academies Press. doi: 10.17226/26421.

×

4:20–4:50	Tobacco Use Data and Surveys Neal D. Freedman Senior Investigator, National Cancer Institute
4:50–5:00	Public comment Note that given the webinar format of the meeting, attendees will need to type their comments into the Q&A box on Zoom, and staff will read them aloud. Note that comments should be related to the committee’s statement of task.
5:00	Closing remarks/open session adjourn

Page 488 Cite

Suggested Citation:"Appendix H: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Premium Cigars: Patterns of Use, Marketing, and Health Effects. Washington, DC: The National Academies Press. doi: 10.17226/26421.

×